Insider · CIK 0002061481
Dorian Paul LeBlanc
Files at LMAT (LEMAITRE VASCULAR INC). First filing -, latest -.
Dorian Paul LeBlanc files SEC Form 4 as CFO at LMAT (LEMAITRE VASCULAR INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Dorian Paul LeBlanc has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 16 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +3 | $0.00 | $0 | 17 | 35 d ago |
| Sep 3, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +4 | $0.00 | $0 | 9 | 35 d ago |
| Jun 4, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +2 | $0.00 | $0 | 14 | Jun 5, 2026 |
| Jun 4, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +3 | $0.00 | $0 | 6 | Jun 5, 2026 |
| Mar 26, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +2 | $0.00 | $0 | 11 | Mar 30, 2026 |
| Mar 26, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +3 | $0.00 | $0 | 3 | Mar 30, 2026 |
| Mar 10, 2026 | LMAT LEMAITRE VASCULAR INC | MOption exercise Common Stock | +2 | $0.00 | $0 | 2,400 | Mar 12, 2026 |
| Mar 10, 2026 | LMAT LEMAITRE VASCULAR INC | FTax withholding Common Stock | -96 | $109.20 | $10k | 2,302 | Mar 12, 2026 |
| Mar 10, 2026 | LMAT LEMAITRE VASCULAR INC | MOption exercise Dividend Equivalent Rightsderivative | -2 | $0.00 | $0 | 9 | Mar 12, 2026 |
| Dec 10, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Common Stock | +1,177 | $0.00 | $0 | 2,398 | Dec 11, 2025 |
| Dec 10, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Stock Option (Right to Buy)derivative | +7,222 | $0.00 | $0 | 7,222 | Dec 11, 2025 |
| Dec 4, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +3 | $0.00 | $0 | 11 | Dec 8, 2025 |
| Sep 4, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +3 | $0.00 | $0 | 8 | Sep 8, 2025 |
| May 29, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +3 | $0.00 | $0 | 6 | Jun 2, 2025 |
| Mar 27, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +3 | $0.00 | $0 | 3 | Mar 31, 2025 |
| Mar 10, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Common Stock | +1,221 | $0.00 | $0 | 1,221 | Mar 21, 2025 |
Questions about Dorian Paul LeBlanc
Answered from the filings on this page, as of the latest one.
Is Dorian Paul LeBlanc buying or selling?
Dorian Paul LeBlanc has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Dorian Paul LeBlanc's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Dorian Paul LeBlanc has 0.
Where does Dorian Paul LeBlanc file Form 4?
Dorian Paul LeBlanc has filed Form 4 at LMAT (LEMAITRE VASCULAR INC) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.